Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

Despite introduction of effective chemotherapy protocols, it has remained uncertain, if patients with colorectal cancer (CRC) liver metastases should receive adjuvant therapy. Clinical or molecular predictors may help to select patients at high risk for disease recurrence and death who obtain a surv...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rahbari, Nuh Nabi (Author) , Reißfelder, Christoph (Author) , Schulze-Bergkamen, Henning (Author) , Jäger, Dirk (Author) , Büchler, Markus W. (Author) , Weitz, Jürgen (Author) , Koch, Moritz (Author)
Format:	Article (Journal)
Language:	English
Published:	11 March 2014
In:	BMC cancer Year: 2014, Volume: 14
ISSN:	1471-2407
DOI:	10.1186/1471-2407-14-174
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-14-174
Author Notes:	Nuh N. Rahbari, Christoph Reissfelder, Henning Schulze-Bergkamen, Dirk Jäger, Markus W. Büchler, Jürgen Weitz and Moritz Koch

Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy by Rahbari, Nuh Nabi (Author) , Reißfelder, Christoph (Author) , Schulze-Bergkamen, Henning (Author) , Jäger, Dirk (Author) , Büchler, Markus W. (Author) , Weitz, Jürgen (Author) , Koch, Moritz (Author) ,

BioMed Central 2014

Resolving-System, kostenfrei, Volltext

Article (Journal) Book/Monograph Online Resource

Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

Similar Items